KYMR · Kymera Therapeutics, Inc.
$117.39
+2.97 (+2.60%)
At close · Aug 14
Market Cap
$9.76B
Shares
83.15M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Nello Mainolfi | Founder, President and Chief Executive Officer | $8,545,609 |
| Brian Adams | Chief Legal Officer | $6,071,041 |
| Noah Goodman | Chief Business Officer | $3,172,068 |
| Jared Gollob | Chief Medical Officer | $2,914,330 |
| Bruce Jacobs | CFA, MBA Chief Financial Officer | $2,903,236 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Nello Mainolfi | Founder, President and Chief Executive Officer | $15,433,147 |
| Bruce Jacobs | CFA, MBA Chief Financial Officer | $7,140,817 |
| Jared Gollob | Chief Medical Officer | $5,749,693 |
| Ellen Chiniara | Chief Legal Officer | $5,140,813 |
| Jeremy Chadwick | Chief Operating Officer | $3,462,173 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Nello Mainolfi | Founder, President and Chief Executive Officer | $9,670,542 |
| Jeremy Chadwick | Chief Operating Officer | $5,001,049 |
| Ellen Chiniara | Chief Legal Officer | $4,962,993 |
| Bruce Jacobs | CFA, MBA Chief Financial Officer | $4,155,156 |
| Jared Gollob | Chief Medical Officer | $3,474,154 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Nello Mainolfi | Founder, President and Chief Executive Officer | $6,926,645 |
| Bruce Jacobs | CFA, MBA Chief Financial Officer | $2,893,316 |
| Jared Gollob | Chief Medical Officer | $2,765,015 |
| Elaine Caughey | Chief Business Officer | $1,684,511 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Nello Mainolfi | Founder, President and Chief Executive Officer | $11,573,374 |
| Bruce Jacobs | CFA, MBA Chief Financial Officer | $4,599,562 |
| Jared Gollob | Chief Medical Officer | $3,500,801 |
| Elaine Caughey | Chief Business Officer | $3,129,295 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Richard Chesworth | Chief Scientific Officer | $4,534,243 |
| Nello Mainolfi | Founder, President and Chief Executive Officer | $3,678,001 |
| Jared Gollob | Chief Medical Officer | $1,452,716 |
| Bruce Jacobs | CFA, MBA Chief Financial Officer | $1,262,902 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Jared Gollob | Chief Medical Officer | $688,199 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Terence Rooney, M.D. | Chief Medical Officer | Appointed | 2026-07-27 |
| Jared Gollob, M.D. | Chief Medical Officer | Retired | 2026-07-27 |
| Jeremy Chadwick | Chief Operating Officer | Retired | 2026-06-08 |
| Brian R. Adams | Chief Legal Officer | Appointed | 2025-09-03 |
| Ellen Chiniara | Chief Legal Officer | Retired | 2025-09-03 |
| Victor Sandor, M.D.C.M. | Class I director | Appointed | 2024-06-20 |
| Pamela Esposito, Ph.D. | Class I director | Appointed | 2024-06-20 |
| Gorjan Hrustanovic, Ph.D. | Class I director | Appointed | 2024-06-20 |
| Joanna Horobin, M.B., Ch.B. | member of the Board of Directors | Resigned | 2024-06-20 |
| Felix J. Baker, Ph.D. | Lead Independent Director | Appointed | 2024-04-01 |
| Felix J. Baker, Ph.D. | Class II director | Appointed | 2024-04-01 |
| Jeremy Chadwick, Ph.D. | Chief Operating Officer | Appointed | 2023-05-22 |
| Victor Sandor, M.D. | Class I director | Appointed | 2022-11-03 |
| Donald Nicholson, Ph.D. | member of the Board of Directors | Resigned | 2022-11-03 |
| Leigh Morgan | Class II director | Appointed | 2022-07-08 |
Key facts
CIK
1815442
CUSIP
501575104
13F (30d)
272 filings
270 filers
Visit website
Investor relations